资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based Inhibitors.

ACS Infectious Diseases. 2018;

Rama Subba Rao Vidadala, Martin Golkowski, Matthew A. Hulverson, Ryan Choi, MollyC. McCloskey, Grant R. Whitman, Wenlin Huang, Samuel L.M. Arnold, Lynn K Barrett,Erkang Fan, Ethan A Merritt, Wesley C. Van Voorhis, Kayode K Ojo, and Dustin J Maly

Products/Services Used	Details	Operation
Peptide Synthesis	Inhibitory effects of BKIs on CpCDPK1 and TgCDPK1;20-21 and off-target inhibition of small gatekeeper human tyrosine kinase, SRC, was determined by indirect measurement of changes in initial reaction ATP concentration after phosphorylation of peptide substrate Syntide 2 (PLARTLSVAGLPGKK) and (Ac-EIYGEFKKK) (GenScript, Piscataway, NJ), respectively, via luminescence with Kinaseglo® as previously described.	Get A Quote

摘要

关键词

Cryptosporidium parvum; Calcium-Dependent Protein Kinase 1 (CpCDPK1) inhibitors; 7H-pyrrolo[2,3-d]pyrimidin-4-amine; 1H-pyrazolo[3,4-d]pyrimidin-4-amine

Article Link >